TSC2 and neoplasm: We curated 32 CNV losses with a definite phenotype from DECIPHER (Additional file 1: Table S6), located in 8 tumor-suppressing CPGs, including APC, CDKN2A, CHEK2, NF1, NF2, RB1, TP53, and TSC2 [61].